Merrimack Pharmaceuticals Inc. buy DERFY
Start price
24.01.17
/
50%
€26.20
Target price
24.07.17
€73.87
Performance (%)
-19.02%
End price
24.07.17
€11.70
Summary
This prediction ended on 24.07.17 with a price of €11.70. The prediction for Merrimack Pharmaceuticals Inc. disappointed with a performance of -19.02%. DERFY has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Merrimack Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | -3.033% | -0.013% | 11.953% | 15.609% |
| iShares Nasdaq 100 | -3.554% | -2.546% | 30.128% | 44.540% |
| iShares Nikkei 225® | -3.938% | 2.183% | 11.741% | 8.345% |
| iShares S&P 500 | -1.517% | -0.882% | 25.752% | 42.388% |
Comments by DERFY for this prediction
In the thread Merrimack Pharmaceuticals Inc. diskutieren
DERFY stimmt dem Sentiment von 'Buy' zu
DERFY stimmt am 24.01.2017 dem Buy-Gesamtsentiment mit dem Kursziel 8.19$ zu.
(Laufzeit überschritten)